TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

TFA Therapeutics (RAJAF) Liabilities from Discontinued Operations (2022 - 2023)

Updated

TFA Therapeutics (RAJAF) posted Liabilities from Discontinued Operations of $949,455 for Q3 2023.

Analysis

TFA Therapeutics (RAJAF) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends

At the end of FY2022, TFA Therapeutics' Liabilities from Discontinued Operations came in at $1.09 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 390.78 Bn 342.58 Bn 11.60 Bn
2 Colgate Palmolive 77.96 Bn 72.79 Bn 3.23 Bn
3 Estee Lauder Companies 41.21 Bn 28.31 Bn 2.81 Bn
4 Kenvue 37.02 Bn 32.73 Bn 2.31 Bn
5 Kimberly Clark 36.84 Bn 32.92 Bn 1.44 Bn
6 Church & Dwight 26.38 Bn 24.77 Bn 749.40 Mn
7 Clorox 12.88 Bn 11.29 Bn 770.00 Mn
8 e.l.f. Beauty 7.00 Bn 5.82 Bn 370.22 Mn
9 Reynolds Consumer Products 5.26 Bn 4.95 Bn 236.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 949,455.00
Dec 31, 2022 1.09 Mn
API Access

TFA Therapeutics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=RAJAF&period=max&api_key=YOUR_API_KEY